Skip to main content
Top
Published in: Journal of Inflammation 1/2011

Open Access 01-12-2011 | Research

Insulin augments tumor necrosis factor-alpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells

Authors: Daniel Z Mackesy, Marc L Goalstone

Published in: Journal of Inflammation | Issue 1/2011

Login to get access

Abstract

Background

Atherosclerosis is an inflammatory disease that is marked by increased presence of Tumor Necrosis Factor-alpha (TNFα), increased expression of Vascular Cell Adhesion Molecule-1 (VCAM-1), increased presence of serum monocytes and activation of the canonical inflammatory molecule, Nuclear Factor Kappa-B (NFκB). Hyperinsulinemia is a hallmark of insulin resistance and may play a key role in this inflammatory process.

Methods

Using Western blot analysis, immunocytochemistry, flow cytometry and biochemical inhibitors, we measured changes in VCAM-1 protein expression and NFκB translocation in vascular endothelial cells in the presence of TNFα and/or hyperinsulinemia and in the absence or presence of kinase pathway inhibitors.

Results

We report that hyperinsulinemia augmented TNFα stimulated increases in VCAM-1 protein greater than seen with TNFα alone and decreased the time in which VCAM-1 translocated to the cell surface. We also observed that in the presence of Wortmannin, a biochemical inhibitor of phosphatidylinositol 3-kinase (a hallmark of insulin resistance), VCAM-1 expression was greater in the presence of TNFα plus insulin as compared to that seen with insulin or TNFα alone. Additionally, nuclear import of NFκB occurred sooner in the presence of insulin and TNFα together as compared to each alone, and in the presence of Wortmannin, nuclear import of NFκB was greater than that seen with insulin and TNFα alone.

Conclusions

hyperinsulinemia and insulin resistance appear to augment the inflammatory effects of TNFα on VCAM-1 expression and NFκB translocation, both of which are markers of inflammation in the vasculature.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lebovitz HE: Type 2 diabetes: an overview. Clin Chem. 1999, 45: 1339-1345.PubMed Lebovitz HE: Type 2 diabetes: an overview. Clin Chem. 1999, 45: 1339-1345.PubMed
2.
go back to reference Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R: Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004, 47: 532-536. 10.1007/s00125-004-1330-x.PubMedCrossRef Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R: Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004, 47: 532-536. 10.1007/s00125-004-1330-x.PubMedCrossRef
3.
go back to reference Okouchi M, Okayama N, Imai S, Omi H, Shimizu M, Fukutomi T, Itoh M: High insulin enhances neutrophil transendothelial migration through increasing surface expression of platelet endothelial cell adhesion molecule-1 via activation of mitogen activated protein kinase. Diabetologia. 2002, 45: 1449-1456. 10.1007/s00125-002-0902-x.PubMedCrossRef Okouchi M, Okayama N, Imai S, Omi H, Shimizu M, Fukutomi T, Itoh M: High insulin enhances neutrophil transendothelial migration through increasing surface expression of platelet endothelial cell adhesion molecule-1 via activation of mitogen activated protein kinase. Diabetologia. 2002, 45: 1449-1456. 10.1007/s00125-002-0902-x.PubMedCrossRef
4.
go back to reference Watson PA, Nesterova A, Burant CF, Klemm DJ, Reusch JE: Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. J Biol Chem. 2001, 276: 46142-46150. 10.1074/jbc.M104770200.PubMedCrossRef Watson PA, Nesterova A, Burant CF, Klemm DJ, Reusch JE: Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. J Biol Chem. 2001, 276: 46142-46150. 10.1074/jbc.M104770200.PubMedCrossRef
5.
go back to reference Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P: Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endo & Metab. 2000, 85: 2572-2575. 10.1210/jc.85.7.2572. Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P: Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endo & Metab. 2000, 85: 2572-2575. 10.1210/jc.85.7.2572.
6.
go back to reference Lele RD: Causation, prevention and reversal of vascular endothelial dysfunction. J Assoc Physicians India. 2007, 55: 643-651.PubMed Lele RD: Causation, prevention and reversal of vascular endothelial dysfunction. J Assoc Physicians India. 2007, 55: 643-651.PubMed
7.
go back to reference Goldschmidt-Clermont PJ, Creager MA, Lorsordo DW, Lam GK, Wassef M, Dzau VJ: Atherosclerosis 2005: recent discoveries and novel hypotheses. Circulation. 2005, 112: 3348-3353. 10.1161/CIRCULATIONAHA.105.577460.PubMedCrossRef Goldschmidt-Clermont PJ, Creager MA, Lorsordo DW, Lam GK, Wassef M, Dzau VJ: Atherosclerosis 2005: recent discoveries and novel hypotheses. Circulation. 2005, 112: 3348-3353. 10.1161/CIRCULATIONAHA.105.577460.PubMedCrossRef
8.
go back to reference Dessein PH, Joffe BI, Singh S: Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther. 2005, 7: R634-643. 10.1186/ar1717.PubMedPubMedCentralCrossRef Dessein PH, Joffe BI, Singh S: Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther. 2005, 7: R634-643. 10.1186/ar1717.PubMedPubMedCentralCrossRef
9.
go back to reference Endemann DH, Schiffrin EL: Endothelial dysfunction. J Am Soc Nephrol. 2004, 15: 1983-1992. 10.1097/01.ASN.0000132474.50966.DA.PubMedCrossRef Endemann DH, Schiffrin EL: Endothelial dysfunction. J Am Soc Nephrol. 2004, 15: 1983-1992. 10.1097/01.ASN.0000132474.50966.DA.PubMedCrossRef
10.
go back to reference Huo Y, Ley K: Adhesion molecules and atherogenesis. Acta Physio Scand. 2001, 173: 35-43. 10.1046/j.1365-201X.2001.00882.x.CrossRef Huo Y, Ley K: Adhesion molecules and atherogenesis. Acta Physio Scand. 2001, 173: 35-43. 10.1046/j.1365-201X.2001.00882.x.CrossRef
12.
go back to reference Yamaguchi K, Higashiura K, Ura N, Murakami H, Hyakukoku M, Furuhashi M, Shimamoto K: The effect of tumor necrosis factor-alpha on tissue specificity and selectivity to insulin signaling. Hypertens Res. 2003, 26: 389-396. 10.1291/hypres.26.389.PubMedCrossRef Yamaguchi K, Higashiura K, Ura N, Murakami H, Hyakukoku M, Furuhashi M, Shimamoto K: The effect of tumor necrosis factor-alpha on tissue specificity and selectivity to insulin signaling. Hypertens Res. 2003, 26: 389-396. 10.1291/hypres.26.389.PubMedCrossRef
13.
go back to reference Inoue K, Zama T, Kamimoto T, Aoki R, Ikeda Y, Kimura H, Hagiwara M: TNFalpha-induced ATF3 expression is bidirectionally regulated by the JNK and ERK pathways in vascular endothelial cells. Genes Cells. 2004, 9: 59-70. 10.1111/j.1356-9597.2004.00707.x.PubMedCrossRef Inoue K, Zama T, Kamimoto T, Aoki R, Ikeda Y, Kimura H, Hagiwara M: TNFalpha-induced ATF3 expression is bidirectionally regulated by the JNK and ERK pathways in vascular endothelial cells. Genes Cells. 2004, 9: 59-70. 10.1111/j.1356-9597.2004.00707.x.PubMedCrossRef
14.
go back to reference Zhang F, Yu W, Hargrove JL, Greenspan P, Dean RG, Taylor EW, Hartle DK: Inhibition of TNF-alpha induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis. 2002, 161: 381-386. 10.1016/S0021-9150(01)00672-4.PubMedCrossRef Zhang F, Yu W, Hargrove JL, Greenspan P, Dean RG, Taylor EW, Hartle DK: Inhibition of TNF-alpha induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis. 2002, 161: 381-386. 10.1016/S0021-9150(01)00672-4.PubMedCrossRef
15.
go back to reference Min JK, Lee YM, Kim JH, Kim YM, Kim SW, Lee SY, Gho YS, Oh GT, Kwon YG: Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Circ Res. 2005, 96: 300-307. 10.1161/01.RES.0000155330.07887.EE.PubMedCrossRef Min JK, Lee YM, Kim JH, Kim YM, Kim SW, Lee SY, Gho YS, Oh GT, Kwon YG: Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Circ Res. 2005, 96: 300-307. 10.1161/01.RES.0000155330.07887.EE.PubMedCrossRef
16.
go back to reference Lu H, Raptis M, Black E, Stan M, Amar S, Graves DT: Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue. Endocrinology. 2004, 145: 4934-4939. 10.1210/en.2004-0737.PubMedCrossRef Lu H, Raptis M, Black E, Stan M, Amar S, Graves DT: Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue. Endocrinology. 2004, 145: 4934-4939. 10.1210/en.2004-0737.PubMedCrossRef
17.
go back to reference Bella J, Rossmann MG: ICAM-1 receptors and cold viruses. Pharm Acta Helv. 2000, 74: 291-297. 10.1016/S0031-6865(99)00056-4.PubMedCrossRef Bella J, Rossmann MG: ICAM-1 receptors and cold viruses. Pharm Acta Helv. 2000, 74: 291-297. 10.1016/S0031-6865(99)00056-4.PubMedCrossRef
18.
go back to reference Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis. 2003, 170: 191-203. 10.1016/S0021-9150(03)00097-2.PubMedCrossRef Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis. 2003, 170: 191-203. 10.1016/S0021-9150(03)00097-2.PubMedCrossRef
19.
go back to reference Wakamoto S, Fujihara M, Takahashi D, Niwa K, Sato S, Kato T, Azuma H, Ikeda H: Enhancement of endothelial permeability by coculture with peripheral blood mononuclear cells in the presence of HLA Class II antibody that was associated with transfusion-related acute lung injury. Transfusion. Wakamoto S, Fujihara M, Takahashi D, Niwa K, Sato S, Kato T, Azuma H, Ikeda H: Enhancement of endothelial permeability by coculture with peripheral blood mononuclear cells in the presence of HLA Class II antibody that was associated with transfusion-related acute lung injury. Transfusion.
20.
go back to reference Narizhneva NV, Razorenova OV, Podrez EA, Chen J, Chandrasekharan UM, DiCorleto PE, Plow EF, Topol EJ, Byzova TV: Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. Faseb J. 2005, 19: 1158-1160.PubMedPubMedCentral Narizhneva NV, Razorenova OV, Podrez EA, Chen J, Chandrasekharan UM, DiCorleto PE, Plow EF, Topol EJ, Byzova TV: Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. Faseb J. 2005, 19: 1158-1160.PubMedPubMedCentral
21.
go back to reference Breen DM, Chan KK, Dhaliwall JK, Ward MR, Al Koudsi N, Lam L, De Souza M, Ghanim H, Dandona P, Stewart DJ, Bendeck MP, Giacca A: Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler Thromb Vasc Biol. 2009, 29: 1060-1066. 10.1161/ATVBAHA.109.185447.PubMedCrossRef Breen DM, Chan KK, Dhaliwall JK, Ward MR, Al Koudsi N, Lam L, De Souza M, Ghanim H, Dandona P, Stewart DJ, Bendeck MP, Giacca A: Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler Thromb Vasc Biol. 2009, 29: 1060-1066. 10.1161/ATVBAHA.109.185447.PubMedCrossRef
22.
go back to reference Wang CC, Sharma G, Draznin B: Early growth response gene-1 expression in vascular smooth muscle cells effects of insulin and oxidant stress. Am J Hypertens. 2006, 19: 366-372. 10.1016/j.amjhyper.2005.10.014.PubMedCrossRef Wang CC, Sharma G, Draznin B: Early growth response gene-1 expression in vascular smooth muscle cells effects of insulin and oxidant stress. Am J Hypertens. 2006, 19: 366-372. 10.1016/j.amjhyper.2005.10.014.PubMedCrossRef
23.
go back to reference Golovchenko I, Goalstone ML, Watson P, Brownlee M, Draznin B: Hyperinsulinemia enhances transcriptional activity of NFκB induced by angiotensin II, hyperglycemia and advanced glycosylation end products in vascular smooth muscle cells. Circ Res. 2000, 87: 746-752.PubMedCrossRef Golovchenko I, Goalstone ML, Watson P, Brownlee M, Draznin B: Hyperinsulinemia enhances transcriptional activity of NFκB induced by angiotensin II, hyperglycemia and advanced glycosylation end products in vascular smooth muscle cells. Circ Res. 2000, 87: 746-752.PubMedCrossRef
24.
go back to reference Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA: Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest. 2000, 106: 571-578. 10.1172/JCI9087.PubMedPubMedCentralCrossRef Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA: Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest. 2000, 106: 571-578. 10.1172/JCI9087.PubMedPubMedCentralCrossRef
25.
go back to reference Zhang W, Wang X, Jin H, Qian R, Zhang G, Chen S, Hu R: Effects of high glucose plus high insulin on proliferation and apoptosis of mouse endothelial progenitor cells. Inflamm Res. 2008, 57: 571-576. 10.1007/s00011-008-8125-3.PubMedCrossRef Zhang W, Wang X, Jin H, Qian R, Zhang G, Chen S, Hu R: Effects of high glucose plus high insulin on proliferation and apoptosis of mouse endothelial progenitor cells. Inflamm Res. 2008, 57: 571-576. 10.1007/s00011-008-8125-3.PubMedCrossRef
26.
go back to reference Goalstone ML, Natarajan R, Standley PR, Walsh MF, Leitner JW, Carel K, Scott S, Nadler J, Sowers JH, Draznin B: Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. Endocrinology. 1998, 139: 4067-4072. 10.1210/en.139.10.4067.PubMed Goalstone ML, Natarajan R, Standley PR, Walsh MF, Leitner JW, Carel K, Scott S, Nadler J, Sowers JH, Draznin B: Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. Endocrinology. 1998, 139: 4067-4072. 10.1210/en.139.10.4067.PubMed
27.
go back to reference Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest. 2001, 107: 1255-1262. 10.1172/JCI11871.PubMedPubMedCentralCrossRef Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest. 2001, 107: 1255-1262. 10.1172/JCI11871.PubMedPubMedCentralCrossRef
28.
go back to reference Goalstone ML, Leitner JW, Draznin B: Mechanism of insulin's ability to potentiate mitogenic effects of growth factors. Advances in Molecular and Cellular Endocrinology. Edited by: LeRoith D. 1999, 155-173. 3 Goalstone ML, Leitner JW, Draznin B: Mechanism of insulin's ability to potentiate mitogenic effects of growth factors. Advances in Molecular and Cellular Endocrinology. Edited by: LeRoith D. 1999, 155-173. 3
29.
go back to reference Festa A, D'Agostino R, Mykkanen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM: Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol. 1999, 19: 562-568. 10.1161/01.ATV.19.3.562.PubMedCrossRef Festa A, D'Agostino R, Mykkanen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM: Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol. 1999, 19: 562-568. 10.1161/01.ATV.19.3.562.PubMedCrossRef
30.
go back to reference Kekalainen P, Sarlund H, Farin P, Kaukanen E, Yang X, Laakso M: Femoral atherosclerosis in middle-aged subjects: association with cardiovascular risk factors and insulin resistance. Am J Epidemiol. 1996, 144: 742-748.PubMedCrossRef Kekalainen P, Sarlund H, Farin P, Kaukanen E, Yang X, Laakso M: Femoral atherosclerosis in middle-aged subjects: association with cardiovascular risk factors and insulin resistance. Am J Epidemiol. 1996, 144: 742-748.PubMedCrossRef
31.
go back to reference Standl E: Hyperinsulinemia and atherosclerosis. Clin Invest Med. 1995, 18: 261-266.PubMed Standl E: Hyperinsulinemia and atherosclerosis. Clin Invest Med. 1995, 18: 261-266.PubMed
32.
go back to reference van de Stolpe A, van der Saag PT: Intercellular adhesion molecule-1. J Mol Med. 1996, 74: 13-33. 10.1007/BF00202069.PubMedCrossRef van de Stolpe A, van der Saag PT: Intercellular adhesion molecule-1. J Mol Med. 1996, 74: 13-33. 10.1007/BF00202069.PubMedCrossRef
33.
go back to reference Watanabe T, Fan J: Atherosclerosis and inflammation mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis. Int J Cardiol. 1998, 66 (Suppl 1): S45-53. discussion S55PubMedCrossRef Watanabe T, Fan J: Atherosclerosis and inflammation mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis. Int J Cardiol. 1998, 66 (Suppl 1): S45-53. discussion S55PubMedCrossRef
34.
go back to reference Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T: Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab. 1998, 83: 2907-2910. 10.1210/jc.83.8.2907.PubMed Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T: Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab. 1998, 83: 2907-2910. 10.1210/jc.83.8.2907.PubMed
Metadata
Title
Insulin augments tumor necrosis factor-alpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells
Authors
Daniel Z Mackesy
Marc L Goalstone
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2011
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-8-34

Other articles of this Issue 1/2011

Journal of Inflammation 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.